electroCore Stock

electroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.

Sign up today and learn more about electroCore Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About electroCore Stock

electroCore LLC is a U.S.-based neuroscience and bioelectronic medicine healthcare technology company dedicated to improving patient outcomes through technological advancement. The company is focused on developing its proprietary non-invasive Vagus Nerve Stimulation (nVNS) therapies for the treatment of multiple conditions in neuropsychology, metabolic disorders and immunology. The company’s initial target is the treatment of primary headache, specifically migraine and cluster headache, and the associated chronic co-morbidities of gastric motility, psychiatric, sleep, and pain disorders that drive disproportionately large direct and indirect costs within the healthcare system and society.

Funding History

November 2012	$500K
June 2014	$55.0M
August 2016	$1.5M
September 2017	$36.0M
November 2017	$34.0M

Management

Chief Medical Officer

Peter S. Staats, MD

Chief Executive Officer

Francis Amato

Global Vice President, Sales and Marketing

Dan Duhart

Vice President, Quality Assurance

Mike Romaniw

Co-Founder, Chief Science & Strategy Officer

J. P. Errico

Vice President, Scientific, Medical and Governmental Affairs

Eric Liebler

Co-Founder and Chief Technical Officer

Steve Mendez

Chief Financial Officer

Glenn S. Vraniak

Vice President, Research

Bruce J. Simon, PhD

Press

BangaloreWeekly - Jun, 27 2018

Electrocore (ECOR) Reaches New 52-Week High After Insider Buying Activity

StockNewsTimes - Jun, 27 2018

Global Health Innovation Merck Buys 166666 Shares of Electrocore LLC (ECOR) Stock

GlobeNewswire (press release) - Jun, 26 2018

electroCore, Inc. Announces Closing of Initial Public Offering

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Join Now

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2023 EquityZen Inc. All rights reserved.